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An inflammatory response is initiated by the temporally controlled activation of genes encoding
a broad range of regulatory and effector proteins. A central goal is to devise strategies for the
selective modulation of proinflammatory gene transcription, to allow the suppression of genes
responsible for inflammation-associated pathologies while maintaining a robust host response to
microbial infection. Toward this goal, recent studies have revealed an unexpected level of diversity
in the mechanisms by which chromatin structure and individual transcription factors contribute to
the selective regulation of inflammatory genes.Introduction
Inflammation evolved as a rapid and highly beneficial response
to microbial infection, tissue injury, and other insults (Nathan
2002; Medzhitov 2008). When host cells capable of innate
immune activation, such as tissue macrophages, encounter
a microbe or another foreign or host irritant, the inflammatory
response initiates within minutes. The host cells first recognize
the stimulus through a wide variety of sensing mechanisms,
often involving transmembrane receptors. These interactions
transmit signals to the nucleus, resulting in the activation of
numerous genes via both transcriptional and posttranscriptional
mechanisms (Akira et al., 2006;Medzhitov 2007; Ishii et al., 2008;
Beutler, 2009). The products of these genes carry out diverse
physiological functions (Foster and Medzhitov, 2009). Some
inducible gene products, such as antimicrobial peptides and
complement factors, directly target infectious microorganisms.
Others, including proinflammatory cytokines and chemokines,
activate endothelial cells and recruit cells of both the innate
and adaptive immune systems to the site of infection. In addition
to their local effects, inducible gene products can act systemi-
cally to induce fever, the acute phase response in the liver, and
other physiological changes.
Although the beneficial role of the inflammatory response
undoubtedly led to its evolution, most researchers study inflam-
mation because of its connection to tissue damage and disease.
Acute inflammation can promote tissue repair, but it can also
damage host tissues. The detrimental effects are further exacer-
bated in a chronic inflammatory state, which has been linked to
a diverse range of diseases, including inflammatory autoimmune
diseases, atherosclerosis, and cancer (Karin et al., 2006; Izcue
et al., 2009). Chronic inflammation arises as a result of the
continual presence of a stimulus or to genetic or physiological
alterations that disrupt normal feedback mechanisms for attenu-
ating the response.
The critical link between chronic inflammation and disease has
led to a search for anti-inflammatory pharmaceuticals that can
be tolerated for an extended time period, without significant
side effects or the suppression of antimicrobial immunity. Onestrategy toward this goal is the suppression of individual inflam-
matory genes or gene products, or specific subsets of genes.
Anti-inflammatory drugs have been developed that inhibit the
functions of specific proteins, such as the tumor necrosis factor
(TNF) receptor and cyclooxygenase-2, but less progress has
been made toward the goal of modulating the transcription of
specific subsets of proinflammatory genes.
Much has been learned about the recognition of inflammatory
stimuli by host receptors, and numerous signal transduction
pathways activated by these receptors have been defined and
characterized. Signal transduction remains a major focal point
for efforts to understand how genes induced by an inflammatory
stimulus are differentially regulated. This focus is highly appro-
priate because differential regulation is dictated largely by differ-
ences in the signal transduction pathways required for transcrip-
tional induction. Moreover, many signal transduction pathways
rely on enzymes that are attractive therapeutic targets. Never-
theless, molecular events orchestrated in the nucleus by
transcription factors and chromatin add additional levels of
complexity and may be equally important for an understanding
of selectivity.
In this article, I summarize recent progress toward under-
standing the contributions of transcription factors and chromatin
to the selective regulation of inducible proinflammatory genes,
with a focus on twomajor themes. First, although a large number
of genes are coordinately induced by a limited set of transcrip-
tion factors during the primary and secondary responses to
a stimulus, detailed studies of specific transcription factors
and of the chromatin organization of proinflammatory genes
have revealed remarkable diversity in the range of mechanisms
employed for transcriptional activation. This mechanistic diver-
sity, which extends well beyond the binding of distinct sets of
inducible transcription factors to different promoters and
enhancers, probably reflects the need for highly specific regula-
tion of each gene in diverse physiological settings. Second,
much of the capacity for selective regulation of genes induced
by an inflammatory stimulus appears to be established at the
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such as macrophages. Thus, selective regulation is likely to
depend just as strongly on the molecular features of proinflam-
matory loci in cells that have not yet encountered a stimulus as
on the properties they acquire upon their induction.
Early Discoveries
Initial efforts to understand the regulation of genes induced by
inflammatory stimuli closely followed the cloning of genes en-
coding key cytokines, including TNF-a, interleukin-1 (IL-1), and
interferon-b (IFN-b). Early studies revealed that the genes encod-
ing these cytokines are potently induced at the transcriptional
level in macrophages and other cell types, with additional post-
transcriptional regulation at the levels of mRNA stability and
translation (Zinn et al., 1983; Beutler and Cerami, 1986; Caput
et al., 1986; Collart et al., 1986; Sariban et al., 1988).
From a transcription perspective, the many genes activated in
response to an inflammatory stimulus can be divided at their
most fundamental level into two classes: primary and
secondary response genes. Primary response genes are usually
activated most rapidly and are formally defined as those genes
that can be induced without de novo protein synthesis (Yama-
moto and Alberts, 1976; Herschman, 1991). In other words,
the transcription factors required for activation of these genes
must be expressed in the unstimulated cell and must be either
constitutively active or activated via posttranslational mecha-
nisms after cell stimulation. Primary response genes are some-
times referred to as immediate early genes, by analogy to viral
genes activated immediately after infection of host cells (Mila-
nesi et al., 1970; Lau and Nathans, 1987). Secondary response
genes are generally induced more slowly and require new
protein synthesis. The transcription of secondary response
genes can depend on the de novo synthesis of transcription
factors, signaling molecules needed for the activation of tran-
scription factors, or cytokines that can act in an autocrine
fashion to activate additional signaling pathways and transcrip-
tion factors. Although secondary response genes require newly
synthesized proteins, the factors responsible for the activation
of primary response genes can also contribute directly to their
transcription. Primary and secondary response genes can be
distinguished by differences in their sensitivity to inhibitors of
protein synthesis, such as cycloheximide (Yamamoto and
Alberts, 1976).
The finding that proinflammatory genes are induced at the level
of transcription inspired efforts to identify DNA motifs and tran-
scription factors that regulate induction. However, the most
important early discoveries emerged from studies of other induc-
ible genesduring aprolificperiodof transcription factor discovery
in the mid-1980s, soon after the first eukaryotic sequence-
specific DNA-binding proteins were reported (Engelke et al.,
1980; Dynan and Tjian, 1983). NF-kB, the first transcription factor
identified whose sequence-specific DNA-binding activity could
be induced by an extracellular stimulus acting via a posttransla-
tional mechanism, was discovered as an LPS-induced protein
that bound an enhancer for the Ig k light-chain gene in B cell
extracts (Sen and Baltimore, 1986). The DNA-binding activity of
NF-kBwas rapidly induced by LPS in the absence of new protein
synthesis, as demonstrated by robust activation in the presence
of cycloheximide.834 Cell 140, 833–844, March 19, 2010 ª2010 Elsevier Inc.Soon after the NF-kB discovery, several other transcription
factors were reported that can be induced via posttranslational
mechanisms and are now known to be key regulators of both
the primary and secondary responses to inflammatory stimuli.
Activator protein-1 (AP-1), a heterodimer of the basic leucine
zipper proteins c-Jun and c-Fos, was discovered as a transcrip-
tion factor that bound sequences in the metallothionine and
SV40 promoters (Greenberg and Ziff, 1984; Lee et al., 1987;
Bohmann et al., 1987; Rauscher et al., 1988). Cyclic-AMP
(cAMP) response element-binding protein (CREB) was discov-
ered as a cAMP-induced factor that regulates induction of the
somatostatin gene in neuroendocrine cells (Montminy and
Bilezikjian, 1987). E2F was discovered as a DNA-binding protein
activated by the adenovirus E1A protein in adenovirus-infected
cells (Kovesdi et al., 1986). Serum response factor (SRF) and
the associated ternary complex factors (TCFs) were identified
through an analysis of the serum induction of Fos transcription
(Treisman, 1986; Prywes and Roeder, 1986; Dalton and Treis-
man, 1992). NFAT was discovered as an inducible DNA-binding
activity that binds the Il2 promoter in activated T cells (Shaw
et al., 1988). These proteins represent only a subset of the tran-
scription factors that are now known to be induced by inflamma-
tory stimuli via posttranslational mechanisms. The posttransla-
tional mechanisms often involve direct phosphorylation or
dephosphorylation of the factors themselves or of inhibitory
proteins. As mentioned above, genes encoding several addi-
tional transcription factors and cofactors are induced at the tran-
scriptional level by inflammatory stimuli (Amit et al., 2009, and
references therein); these newly synthesized factors can
contribute to the secondary response in concert with factors
whose activities are induced posttranslationally.
The Enhanceosome Model
The selective transcription of each proinflammatory gene is
regulated by a promoter that spans the transcription start site
and, at most or all genes, by one or more distant enhancers.
Each promoter and enhancer contains DNA motifs recognized
by a collection of sequence-specific DNA-binding proteins
(i.e., transcription factors). Studies of proinflammatory gene
transcription have mostly focused on promoters because
promoters can easily be identified as a result of their close prox-
imity to the start site. Moreover, promoters for proinflammatory
genes are generally sufficient to support inducible transcription
in transfection assays with promoter-reporter plasmids.
However, distant enhancers have now been identified for
a number of proinflammatory genes and are likely to be essential
for proper transcriptional regulation in a native chromatin envi-
ronment (Carey et al., 2009). In a native environment, transcrip-
tional activation appears to require close physical proximity
between the promoter and distant enhancers, with ‘‘looping
out’’ of the intervening DNA (Lee et al., 2006; de Laat et al.,
2008). Although most studies have focused on long-range inter-
actions between enhancers and promoters, a recent study
suggests that inducible factors like NF-kB are delivered to the
promoters of target genes by long-range interactions between
the promoters and unlinked genomic locations at which the
factors accumulate after their initial induction (Apostolou and
Thanos, 2008).
The finding that numerous transcription factors are induced by
an inflammatory stimulus suggests a simple model in which the
selective activation of a given gene depends on the induction
of a defined set of signal transduction pathways, which activate
a defined set of transcription factors capable of binding the DNA
motifs present in the promoter and enhancers of that gene.
According to this model, the factors will activate transcription
synergistically, perhaps by binding cooperatively to the control
regions and forming a three-dimensional composite surface for
the recruitment of the coactivators, chromatin remodeling
complexes, and general transcription factors needed for tran-
scription initiation by RNA polymerase II.
Detailed studies of human IFNB activation upon Sendai virus
infection have demonstrated the central role of cooperative
binding and synergy between multiple sequence-specific DNA-
binding proteins in selective transcriptional activation (Thanos
and Maniatis, 1995; Agalioti et al., 2000). The regulatory region
of the IFNB promoter consists of a 55 bp DNA sequence with
greater than 90% identity between mouse and human. In
extracts from Sendai virus-infected cells, a highly stable multi-
protein complex, termed an enhanceosome, assembles on this
DNA region through the cooperative binding of the inducible
transcription factors NF-kB, IRF3/IRF7, and ATF-2/c-Jun
(Thanos and Maniatis, 1995). Structural studies have revealed
that virtually every base pair within the 55 bp region is directly
contacted by at least one of the DNA-binding proteins, explain-
ing the strong sequence conservation through evolution (Panne
et al., 2004, 2007). Interestingly, direct protein-protein interac-
tions between the transcription factors play only a minimal role
in cooperative binding. Instead, cooperativity is largely due to
conformational changes in the DNA upon factor binding that
facilitate the binding of other factors to adjacent and overlapping
sites (Panne et al., 2004, 2007). Cooperativity may also benefit
from the concerted association of multiple enhanceosome
factors with common coactivators, such as p300.
In vivo and in vitro studies have provided evidence that the
conserved IFNB promoter region is nucleosome free in unin-
fected cells, but a stable nucleosome encompasses the down-
stream TATA box (Agalioti et al., 2000; Lomvardas and Thanos,
2002). Assembly of the enhancesome upon activation of the rele-
vant transcription factors leads to the sequential recruitment of
the p300 and GCN5 histone acetyltransferases and SWI/SNF
nucleosome remodeling complex, resulting in sliding of the
TATA-associated nucleosome to a downstream location. Nucle-
osome displacement allows recruitment of the transcription
factor IID (TFIID) complex that contains the TATA-binding protein
(TBP), along with other general transcription factors and RNA
polymerase II.
The IFNB studies document one mechanism by which selec-
tive gene activation can be achieved: transcription is activated
only by stimuli that activate all transcription factors that associate
with the enhanceosome, because of the apparent requirement
for highly cooperative binding and synergistic functions. This
mechanism helps explain why stimuli acting through Toll-like
receptors 3 and 4 (TLR3 and TLR4) lead to IFNB activation,
whereas IFNB transcription is not activated by bacterial stimula-
tion of TLR2; TLR2stimulation bybacteria does not activate IRF3,
although it activates NF-kB and ATF-2/c-Jun (Doyle et al., 2002).The importance of synergy between multiple inducible tran-
scription factors and the signal transduction pathways respon-
sible for their activation cannot be overemphasized, as syner-
gistic activation is likely to play a major role in the selective
regulation of many or all genes. Indeed, combinatorial regula-
tion of transcription was postulated more than 40 years ago
to be essential for a limited number of transcriptional factors
to coordinate the diverse gene expression patterns observed
in multicellular organisms (Britten and Davidson, 1969;
Georgiev, 1969; Gierer, 1973). However, highly cooperative
binding by all inducible transcription factors required for the func-
tion of a promoter may be much less common. First, it is rare to
find promoters like the IFNB promoter, with greater than 90%
sequence conservation between human and mouse through an
extended region (Arnosti and Kulkarni, 2005). Second, highly
stable protein-DNA complexes containing several cooperatively
bound proteins have rarely been reported. Third, a growing
body of evidence suggests that a subset of key transcription
factors, including NF-kB, nuclear hormone receptors, and yeast
activators such as Gal4 and Gcn4 associate dynamically or
transiently with promoter DNA, with the dynamic association
possibly required for transcriptional activation (Lipford et al.,
2005; Muratani et al., 2005; Bosisio et al., 2006; Hager et al.,
2009). Fourth, even at the IFNB promoter, key transcription
factors have been found to associate sequentially rather
than simultaneously after Sendai virus infection (Munshi et al.,
2001). Thus, an understanding of selective activation cannot
be reduced to the goal of isolating and characterizing stable
protein-DNA complexes. As described below, selective activa-
tion appears to be achieved through mechanisms that extend
well beyond the basic induction of DNA-binding proteins
and their differential binding to DNA motifs in promoters and
enhancers.
Selective Regulation by NF-kB
Studies of transcriptional regulation by NF-kB have provided
considerable insight into the diverse mechanisms that have
evolved to regulate distinct sets of inducible genes. The NF-kB
family consists of five members: p50, p52, RelA, c-Rel, and
RelB (Ghosh et al., 1998). The Rel homology region (RHR) that
defines the NF-kB family supports sequence-specific DNA
binding and the formation of stable homodimers and hetero-
dimers. RelA, c-Rel, and RelB contain C-terminal activation
domains, whereas p50 and p52 lack definable activation
domains. Most NF-kB proteins are retained in the cytoplasm of
resting cells by ankyrin repeat-containing IkB proteins (Ghosh
et al., 1998; Hoffmann et al., 2006; Vallabhapurapu and Karin,
2009). Some IkBs are encoded by separate genes. However,
p50 and p52 are initially synthesized as the precursor proteins
p105 and p100, respectively, which contain IkB-like ankyrin
repeat domains at their C terminus; these domains are often
removed by constitutive proteolytic processing, but they can
remain covalently associated with some NF-kB homodimers or
heterodimers in the cytoplasm (Vallabhapurapu and Karin,
2009). A detailed biochemical analysis recently revealed a
surprisingly diverse range of dimeric and multimeric NF-kB/IkB
complexes in the cytoplasm of unstimulated cells (Savinova
et al., 2009).Cell 140, 833–844, March 19, 2010 ª2010 Elsevier Inc. 835
Figure 1. Diverse Mechanisms of Selective Gene Activation by
NF-kB
(A) A model of the IFNB enhanceosome is shown (adapted from Panne et al.,
2007). The highly cooperative binding and synergistic function of multiple tran-
scription factors has been found to play a major role in the selective activation
of the human IFNB gene (Thanos and Maniatis, 1995; Agalioti et al., 2000).
Synergy between multiple transcription factors activated by diverse signal
transduction pathways is likely to be critical for the selective activation of all
genes induced by inflammatory stimuli.
(B) Analysis of mice containing a mutation in the RelA S276 phosphoacceptor
site have revealed that a select subset of NF-kB target genes depend on S276
phosphorylation (Dong et al., 2008), which promotes an interaction between
NF-kB and the p300/CBP coactivators (Zhong et al., 1998, 2002). Thus,
a subset of NF-kB target genes will be activated only by stimuli that activate
PKAc or other kinases that can phosphorylate RelA S276.
(C) The Nfkibz gene, which encodes the nuclear IkB protein, IkBz, is activated
at the transcriptional level during the primary response to LPS and other
inflammatory stimuli (Yamamoto et al., 2004; Motoyama et al., 2005). IkBz is
subsequently required for the activation of a select subset of secondary
836 Cell 140, 833–844, March 19, 2010 ª2010 Elsevier Inc.NF-kB dimers retained in the cytoplasm can be activated by
either of two fundamentally distinct pathways, referred to as
the type 1 and type 2 pathways (Vallabhapurapu and Karin,
2009). The abundant p50:RelA and p50:c-Rel heterodimers, as
well as several other dimeric species, are activated by the clas-
sical type 1 pathway, which involves phosphorylation of the
associated IkB, leading to its ubiquitylation and proteosome-
mediated degradation, thereby releasing the NF-kB dimer to
translocate to the nucleus (Ghosh et al., 1998; Hoffmann et al.,
2006; Vallabhapurapu and Karin, 2009). In contrast, p52:RelB
dimers are often activated by the type 2 pathway, which involves
inducible proteolytic removal of the ankryin-repeat domain of
the p100:RelB heterodimer, releasing p52:RelB to translocate
to the nucleus.
Although inducible nuclear translocation is critical for NF-kB
activation, NF-kB’s capacity to activate transcription depends
on additional layers of regulation, with different regulatory layers
at different NF-kB target genes (Figure 1). As one example, acti-
vation of some target genes depends on the inducible phosphor-
ylation of RelA (Figure 1B). Mouse RelA is phosphorylated by
cyclic AMP-dependent protein kinase (PKAc) on serine 276
(S276), which results in a conformational change that exposes
an interaction surface for the transcriptional coactivators p300
and CBP (Zhong et al., 1998, 2002). Importantly, targeted muta-
tion of RelA S276 led to defective activation of some but not all
NF-kB target genes in TNFa-stimulated fibroblasts; Cxcl2 and
Tnf transcription was reduced, but transcription of Il6, Ptgs2,
and Nfkbia was unaffected (Dong et al., 2008). Thus, NF-kB-
mediated recruitment of the p300/CBP coactivators, which
contain an acetyltransferase domain capable of acetylating
core histones, is differentially required at NF-kB target genes.
This differential requirement may allow some genes to be acti-
vated by any stimulus that promotes IkB phosphorylation and
degradation, whereas other genes will be activated only when
IkB phosphorylation is accompanied by the activation of
PKAc or other kinases that can phosphorylate RelA S276. Inter-
estingly, transcriptional activation by c-Rel, whose RHR is highly
homologous to that of RelA, does not appear to be influenced by
p300/CBP (Wang et al., 2007). This difference may restrict the
activation of p300/CBP-dependent NF-kB target genes to RelA
homodimers or heterodimers.
Recently, methylation of RelA lysine 37 (K37) by the Set9
methyltransferase was identified as another posttranslational
modification that can contribute to the selective regulation of
NF-kB target genes (Ea and Baltimore, 2009). Both Set9 and
RelA K37 were found to be important for activation of the Tnf
andCxcl10 genes, but not theNfkbia gene, in TNFa-treated cells.
Microarray experiments performed in an independent study sug-
gested that Set9 is important for the activation of approximatelyresponse genes. Activation of these genes therefore depends on all signal
transduction pathways needed for Nfkibz transcriptional activation.
(D) An interaction between RelA and the Med17 subunit of the Mediator
complex is needed for activation of a select subset of NF-kB target genes
(van Essen et al., 2009). Other inducible transcription factors may be
responsible for recruitment of the Mediator complex to other NF-kB target
genes, thereby conferring a requirement for these factors for transcriptional
activation.
25% of NF-kB target genes in TNFa-treated monocytes (Li et al.,
2008). K37 methylation appears to stabilize NF-kB binding to
some recognition motifs and may therefore promote the tran-
scription of a select subset of target genes that benefit from
this enhanced stability (Ea and Baltimore, 2009). Notably, all
NF-kB family members appear to be extensively modified at
a posttranslational level (Perkins, 2006); the modified residues
will need to be disrupted by targeted mutagenesis in mice
(similar to the S276 mutagenesis experiments) to evaluate the
importance of each modification for NF-kB function.
NF-kB target genes also exhibit differential dependence on
nuclear IkB proteins, which function as transcriptional coactiva-
tors by interacting with NF-kB dimers associated with target
genes (Yamamoto and Takeda, 2008). One example is IkBz,
whose gene, Nfkbiz, is activated at the transcriptional level in
macrophages during the primary response to an inflammatory
stimulus (Yamamoto et al., 2004; Motoyama et al., 2005).
Because IkBz expression is induced during the primary
response, all NF-kB target genes that rely on this factor for their
activation will be secondary response genes (Figure 1C). Indeed,
an analysis of Nfkbiz/ mice revealed that primary response
genes, such as Cxcl1, Cxcl2, and Il23a, were induced in an
Nfkbiz-independent manner, whereas a subset of secondary
response genes, including Il12b, Il6, and Lcn2, exhibited Nfkbiz
dependence (Yamamoto et al., 2004). After its inducible
synthesis, IkBz appears to associate with NF-kB p50 homo-
dimers associated with inactive genes, thereby facilitating their
transcriptional activation (Yamamoto et al., 2004). The molecular
mechanism by which IkBz promotes the activation of NF-kB
target genes remains unknown, although it appears to act prior
to preinitiation complex assembly and histone H3K4 trimethyla-
tion at target gene promoters (Kayama et al., 2008). Most impor-
tantly, IkBz-dependent NF-kB target genes are likely to be acti-
vated in a highly selective manner, as activation of these genes
will require all signal transduction pathways needed for transcrip-
tional induction of the Nfkbiz gene, in addition to signaling path-
ways required for nuclear translocation of NF-kB. The two other
nuclear IkB proteins, Bcl3 and IkBNS, appear to make additional
contributions to the selective regulation of inducibleNF-kB target
genes (Leung et al., 2004; Yamamoto and Takeda, 2008).
NF-kB activation mechanisms are further diversified through
differential interactions with components of the general tran-
scription machinery. This potential contribution to selective
gene activation emerged from an analysis of NF-kB’s interaction
with theMediator complex, which is essential for the activation of
most eukaryotic genes by facilitating the recruitment of the
general transcription machinery and RNA polymerase II by tran-
scriptional activators (Malik and Roeder, 2005). RelA was found
to associate with the Med17 (Trap80) subunit of the Mediator
complex (van Essen et al., 2009), leading to the initial hypothesis
that the RelA-Med17 interaction may be critical for the activation
of all NF-kB target genes. Surprisingly, however, Med17 knock-
down by RNA interference (RNAi) revealed that this Mediator
subunit is needed for activation of only a subset of target genes,
including Ptgs2, Il6, and Cxcl10, while the expression of Cxcl2,
Nfkbia, and many other inducible genes was unaffected
(Figure 1D). In contrast to the p300/CBP and IkBz selectivity
mechanisms described above, it is not yet known whether theselective requirement for the NF-kB-Med17 interaction leads to
a requirement for different signal transduction pathways at
Med17-dependent and -independent genes. One possibility is
that Med17-independent NF-kB target genes require the induc-
tion of another transcription factor that can recruit the Mediator
through a direct interaction with a different Mediator subunit.
The above findings reveal a clear theme in which at least some
posttranslational modifications and cofactors involved in NF-kB
activation contribute to the activation of only a small subset of
NF-kB target genes. At a mechanistic level, much remains to
be learned about these differential contributions. We can specu-
late that this mechanistic diversity plays an important role in
facilitating the differential regulation of NF-kB target genes in
different physiological settings. It is tempting to speculate, for
example, that the subset of NF-kB target genes that require an
inducible interaction with p300/CBP are coordinately and selec-
tivity activated in certain physiological circumstances, while
target genes requiring IkBz will remain inactive under those
same conditions because of the absence of Nfkbiz transcrip-
tional induction. Hopefully, these connections between activa-
tion mechanisms and physiological responses will become
apparent as more detailed knowledge is gained about the
specific subsets of genes that rely on each activation mecha-
nism, as well as the specific subsets of genes that are induced
in different physiological settings. Finally, although I have
focused on NF-kB, other inducible transcription factors are likely
to exhibit similar levels of diversity in the mechanisms by which
they activate specific sets of target genes.
Role of Chromatin Structure and Development
in Selective Regulation
Early Advances
Although most studies of gene induction by inflammatory stimuli
have focused, quite appropriately, on transcription factors that
recognize specific DNA sequences, transcriptional activation
of eukaryotic genes is also influenced by chromatin structure.
The fundamental repeating unit of chromatin is the nucleosome,
which consists of a histone octamer containing two molecules
each of the core histones H2A, H2B, H3, and H4 (Luger et al.,
1997). Linker histones, histone variants, and many nonhistone
proteins make additional contributions to the structure of chro-
matin found in eukaryotic cells. Molecular evidence that chro-
matin may be more accessible to transcription factors and
RNA polymerase at active genes than at inactive genes was
obtained in the 1970s through the analysis of locus-specific
differences in sensitivity and hypersensitivity to cleavage by
nucleases added to cell nuclei or permeabilized cells (Weintraub
and Groudine, 1976; Wu et al., 1979; Carey et al., 2009). The Il2
cytokine gene was among the initial group of genes found to
exhibit changes in nuclease hypersensitivity upon transcriptional
induction (Siebenlist et al., 1986). In the 1980s and early 1990s,
evidence began to emerge that the N-terminal tails of core
histones and the posttranslational modification of these tails
may contribute to transcriptional regulation (Grunstein, 1990).
However, conclusive evidence that chromatin plays a direct
role in transcriptional regulation was not obtained until the
mid-1990s. At that time, Gcn5, a transcriptional coactivator in
S. cerevisiae, was found to catalyze the acetylation of histoneCell 140, 833–844, March 19, 2010 ª2010 Elsevier Inc. 837
H3, providing definitive evidence that the covalent modification
of histones can contribute to transcriptional control (Brownell
et al., 1996). In addition, biochemical experiments revealed
that the SWI/SNF complex, originally identified by classical
genetics as an important regulator of a specific subset of yeast
genes (Neigeborn and Carlson, 1984; Stern et al., 1984), uses
the energy of ATP hydrolysis to catalyze changes in nucleosome
conformation (Coˆte´ et al., 1994; Imbalzano et al., 1994; Kwon
et al., 1994). These conformational changes, referred to as
nucleosome remodeling, make genomic DNA more accessible
to transcription factor binding, either through the translocation
or eviction of nucleosomes or a change in their conformation
(Clapier and Cairns, 2009).
One of the first clear connections between nucleosome re-
modeling and the regulation of inducible transcription in cells
of the immune system was the observation that mammalian
SWI/SNF complexes are recruited rapidly and efficiently to chro-
matin after the activation of resting T cells (Zhao et al., 1998).
SWI/SNF association coincided with global decondensation of
the chromatin, consistent with the view that decondensation is
needed for T cell activation. However, SWI/SNF binding was
not observed until the first wave of inducible transcription had
begun (Zhao et al., 1998), providing initial evidence that nucleo-
some remodeling by SWI/SNF complexes may not be required
for the activation of all inducible genes.
Variable Requirements for Nucleosome Remodeling
at Inducible Genes
A second major conceptual advance was provided by Saccani
et al. (2001), who found that NF-kB associates with its target
genes in LPS-stimulated macrophages with variable kinetics.
In chromatin immunoprecipitation (ChIP) experiments, NF-kB
bound the Cxcl2 and Nfkbia promoters as soon as it entered
the nucleus, whereas binding to the promoters for Ccl5, Il6,
and other genes was substantially delayed. An attractive expla-
nation for this differencewas that a chromatin barrier needs to be
overcome for NF-kB binding to some but not all target genes.
Saccani et al. hypothesized that the nucleosome barrier provides
a potential mechanism for selectively regulating NF-kB target
genes, as additional transcription factors could control NF-kB
access by regulating the recruitment of remodeling factors.
Subsequent studies revealed variable requirements for SWI/
SNF nucleosome remodeling complexes at genes induced by
LPS in mouse macrophages (Ramirez-Carrozzi et al., 2006).
This variability is likely to explain, at least in part, the different
kinetics of NF-kB binding. Analysis of macrophages in which
the core Brg1 and Brm ATPase subunits of the mammalian
SWI/SNF complexes had been depleted by retroviral delivery
of short hairpin RNAs (shRNAs) revealed that most primary
response genes are induced by LPS in a SWI/SNF-independent
manner, with almost all secondary response genes exhibiting
SWI/SNF dependence. SWI/SNF dependence was also
observed at a subset of primary response genes that were
generally induced with delayed kinetics. The promoters of repre-
sentative SWI/SNF-independent genes were found to be acces-
sible to nuclease cleavage in nuclei from both unstimulated and
stimulated cells; in contrast, the promoters of SWI/SNF-depen-
dent genes exhibited low nuclease accessibility prior to cell
stimulation, with increased accessibility following stimulation,838 Cell 140, 833–844, March 19, 2010 ª2010 Elsevier Inc.suggestive of inducible nucleosome remodeling (Ramirez-
Carrozzi et al., 2006). SWI/SNF-independent promoters also
exhibited constitutively high histone acetylation and histone
H3K4 trimethylation, providing further support for the view that
these promoters are assembled, prior to stimulation, into a chro-
matin structure similar to that found at active genes (Ramirez-
Carrozzi et al., 2006, 2009).
Regulation of SWI/SNF-Independent Genes
Importantly, SWI/SNF-independent primary response genes
usually contain CpG island promoters, whereas SWI/SNF-
dependent primary and secondary response genes almost
always contain promoters with a low CpG content (Ramirez-
Carrozzi et al., 2009). In vitro nucleosome assembly experiments
revealed that nucleosomes assembled on CpG island promoters
are less stable than those assembled on low CpG promoters.
This finding is consistent with a large body of evidence that prop-
erly spaced AA/TT dinucleotides, which are deficient at most
CpG island promoters, are required for stable nucleosome
assembly (Segal et al., 2006, and references therein). This
intrinsic instability may facilitate rapid transcriptional activation
of primary response genes containing CpG islands in the
absence of a nucleosome remodeling requirement. Remodel-
ing-independent activation may also benefit from the high prev-
alence of binding sites for constitutive transcription factors, such
as Sp1, in CpG island promoters; binding of Sp1 and other
constitutively expressed factors may contribute to the SWI/
SNF independence of these promoters and may be responsible
for their constitutive histone acetylation andH3K4 trimethylation,
as well as for the low level of constitutive transcription frequently
observed at these promoters (Ramirez-Carrozzi et al., 2009).
Recent studies have elucidated the molecular mechanism by
which primary response genes can be efficiently induced in a
stimulus-dependent manner, despite their constitutive assembly
into a chromatin structure resembling that found at active genes.
Although low levels of precursor transcripts are constitutively
produced at these genes, NF-kB and possibly other inducible
factors are needed to enhance the efficiency of transcription
elongation and pre-mRNA processing, in addition to enhancing
the frequency of transcription initiation (Amir-Zilberstein et al.,
2007; Hargreaves et al., 2009). These inducible factors promote
acetylation of histone H4K5, K8, and K12, with the acetyl lysines
then recognized by the bromodomain-containing adaptor
protein Brd4. Brd4 recruits P-TEFb, which promotes elongation
and pre-mRNA processing through its ability to phosphorylate
the C-terminal domain of RNA polymerase II (Hargreaves et al.,
2009, and references therein).
Selective Regulation Conferred by a Nucleosome
Barrier
As initially proposed by Saccani et al. (2001), the nucleosome
barrier found at most secondary response genes and some
primary response genes provides an attractive strategy for
differentially regulating the induction of specific subsets of genes
by inflammatory stimuli. Stimulus-specific transcription factors
may facilitate the recruitment of SWI/SNF complexes to distinct
sets of remodeling-dependent genes, allowing their selective
activation. Consistent with this hypothesis, a substantial subset
of SWI/SNF-dependent LPS-induced primary response genes
was found to require IRF3 for their activation and the promoters
for these genes usually contain consensus IRF3 binding sites
(Ramirez-Carrozzi et al., 2009). Inducible nucleosome remodel-
ing at these promoters, analyzed by restriction enzyme accessi-
bility, was absent in LPS-stimulated macrophages from IRF3/
mice, demonstrating that IRF3 promotes nucleosome remodel-
ing, either directly or indirectly, at this select subset of LPS-
induced primary response genes.
The observation that SWI/SNF complexes are consistently
needed for the activation of IRF3-dependent genes suggests
that the nucleosome barrier at the promoters for these genes is
critical for restricting their activation to stimuli that efficiently
induce IRF3. Striking evidence in support of this hypothesis
was provided by Lomvardas and Thanos (2002) through their
analysis of the IRF3-dependent IFNB promoter, discussed
above as a paradigm for the enhanceosome model. Despite
strong evidence that IRF3, NF-kB, andATF-2/c-Jun forma stable
enhanceosome at the IFNB promoter, displacement of the TATA
box-encompassing nucleosome through the use of an artificial
nucleosome positioning sequence resulted in efficient IRF3-
independent promoter activity. Thus, NF-kB and ATF-2/c-Jun
appear to be quite effective in stimulating IFNB promoter activity
in the absence of IRF3 when the nucleosome barrier is elimi-
nated. This suggests that the nucleosome barrier at IRF3-depen-
dent genes is more important than cooperative binding of the full
complement of transcription factors for selective regulation. That
is, the nucleosome barrier appears to be the main reason IFNB
transcription is induced by TLR3 and TLR4, which activate
IRF3, but not by TLR2 or TNFa, which do not activate this factor
(Doyle et al., 2002).
Interestingly, at representative SWI/SNF-dependent sec-
ondary response promoters, including the Il12b, Il6, and Nos2
promoters, nucleosome remodeling as monitored by restriction
enzyme accessibility and the recruitment of SWI/SNF complexes
is strongly dependent on newprotein synthesis (Weinmann et al.,
1999; Ramirez-Carrozzi et al., 2006). Therefore, a major mecha-
nism for restricting the activation of many secondary response
genes is through their requirement for specific primary response
gene products to promote the recruitment of SWI/SNF
complexes. Unfortunately, the identities of the primary response
proteins that drive remodeling at specific subsets of secondary
response genes have not yet been determined. Notably, nucleo-
some remodeling by SWI/SNF complexes may be subject to
additional regulatory layers that can further enhance the extent
to which a remodeling requirement can contribute to selective
activation. In particular, nucleosome remodeling at the pro-
moters of LPS-induced genes was found to require a calcium
signaling pathway, which promotes the activation of SWI/SNF
complexes after their recruitment to target genes (Lai et al.,
2009).
Taken together, the above results reveal that an understanding
of selectivity requires, not only the identification of transcription
factors induced by various stimuli, but also an understanding of
the chromatin state of inducible loci in differentiated cells that
have not yet encountered a stimulus. For example, the studies
described above suggest that IRF3 dependence in macro-
phages is achieved by the assembly of IRF3-dependent
promoters into stable nucleosomes during macrophage devel-
opment, whereas the promoters of most IRF3-independentprimary response genes are assembled into constitutively
accessible chromatin due to the presence of CpG island
promoters.
Extensive Chromatin Diversity at the Promoters
of Inducible Genes prior to Their Activation
Several additional studies of chromatin structure at promoters
induced by inflammatory stimuli have revealed a surprising
degree of variability in mature unstimulated cells (Figure 2).
One early example was the finding that histone H3K9 methyla-
tion, which generally correlates with transcriptional repression,
is readily apparent at the promoters of some but not all inducible
genes in unstimulated human dendritic cells (Saccani and Natoli,
2002). H3K9methylationwas observed at the IL12B,CCL19, and
CCL22 promoters in unstimulated cells and was rapidly lost
upon LPS stimulation. However, this repressive mark was not
observed at the CCL3, IL8, and NFKBIA promoters. This finding
suggests a model in which transcriptional activation of a select
subset of LPS-induced genes requires the recruitment and
function of an H3K9 demethylase. Although the identity of the
H3K9 demethylase remains to be established, the regulation of
this demethylase, either through the regulation of its expression
or the direct regulation of its catalytic activity, could play a major
role in the differential regulation of genes that contain or lack
H3K9 methylation in unstimulated cells.
H3K27 methylation, another repressive histone modification,
which acts by recruiting polycomb complexes, has also been
identified at a select subset of inducible genes prior to their acti-
vation (De Santa et al., 2007, 2009). Furthermore, a histone de-
methylase, Jmjd3, was found in genome-wide ChIP experiments
to be associated in unstimulated macrophages with a small
subset of inducible genes (De Santa et al., 2007, 2009). Interest-
ingly, although Jmjd3 can demethylate methylated H3K27, the
subset of genes associated with Jmjd3 differed from the subset
marked by methyl H3K27.
Further variability in the chromatin features of inducible genes
in resting macrophages was uncovered through analyses of the
corepressors NCoR (nuclear receptor corepressor) and SMRT
(silencing mediator of retinoic acid and thyroid hormone recep-
tors) (Jepsen and Rosenfeld, 2002). These corepressors, which
function in part through the recruitment of histone deacetylases,
appear to be associated with overlapping subsets of inducible
genes in resting cells through their interaction with different
DNA-binding proteins (Ghisletti et al., 2009). For example,
NCoR is specifically associated with the Mmp13 promoter,
SMRT is specifically associated with the Il12b promoter, and
both NCoR and SMRT are associated with the Ccl2 promoter
in unstimulated macrophages. The Ets-domain protein TEL
appears to be responsible for NCoR association, with c-Jun
homodimers and NF-kB p50 homodimers contributing to
SMRT association (Ghisletti et al., 2009). The binding of these
corepressors to distinct subsets of target genes in resting cells
has the potential to contribute to their selective activation.
Role of Developmental Events in Chromatin Diversity
The above examples underscore the hypothesis that differences
in chromatin structure at the promoters of inducible genes in
resting cells are likely to play a critical role in their selective acti-
vation. Most likely, these chromatin differences are established
during the development of macrophages and other responsiveCell 140, 833–844, March 19, 2010 ª2010 Elsevier Inc. 839
Figure 2. Diverse Chromatin Barriers to
Inflammatory Gene Induction
(A) Most genes activated during the primary
response to an inflammatory stimulus are poised
for activation by their constitutive assembly into
a chromatin structure resembling that found at
constitutively active genes (Ramirez-Carrozzi
et al., 2009; Hargreaves et al., 2009). At some of
these genes, inducible transcription factors may
not need to remove chromatin barriers, but these
factors must instead enhance transcription initia-
tion, elongation, and pre-mRNA processing. Genes
within this class are generally induced promiscu-
ouslybyawiderangeofgenericsignalingpathways.
(B) The assembly of promoters and other control
regions into stable nucleosomes provides a
substantial barrier to transcriptional activation
(Ramirez-Carrozzi et al., 2009). SWI/SNF com-
plexes are often required for the remodeling of
thesenucleosomes. Inducible remodeling,asmon-
itoredby restrictionenzymeaccessibility, is likely to
require specialized transcription factors that are
either directly activated by a stimulus, such as
IRF3, or encoded by genes expressed during the
primary response to the stimulus. The nucleosome
remodeling requirement contributes to the tight
regulation of SWI/SNF-dependent genes.
(C and D) ChIP analyses of large panels of promoters and genome-wide ChIP-Seq experiments have revealed that histone H3K9 and histone H3K27 are heavily
methylatedat small subsets of inducible promoters inmature unstimulated cells (Saccani andNatoli, 2002;DeSanta et al. 2007, 2009). Transcriptional activation of
thesegenesgenerally coincideswith the loss of histoneH3K9orH3K27methylation, suggesting that the demethylation or histone replacementmaybe required for
activation. Nucleosome remodeling may also be required for activation of these genes before or after removal of the histone methylation.
(E and F) The NCoR and SMRT corepressor complexes appear to be associated with distinct subsets of inducible genes in mature, unstimulated cells (Ghisletti
et al., 2009;Hargreaves et al., 2009). Transcriptional activation requires the removal of these co-repressor complexes,whichcontain histonedeaceylases (HDACs)
and other subunits that may help maintain a repressive chromatin structure.cell types. It is well established that transcription factor interac-
tions with the control regions of inducible and tissue-specific
genes, and changes in chromatin structure at these genes, can
begin early in development and long before the genes are ex-
pressed, sometimes as early as the embryonic stem cell stage
(Lefevre et al., 2008; Zaret et al., 2008; Xu et al., 2009, and refer-
ences therein). However, the developmental events that lead, for
example, to H3K9 or H3K27 methylation at a select subset of
inducible genes in mature resting cells remain undefined. These
chromatin differencesmust be dictated by specific DNAmotifs in
the promoters and distal control regions of the inducible genes.
However, in most instances, the transcription factors involved
and the developmental stage at which the chromatin state is es-
tablished have not been determined.
Consistent with the proposal that developmental events play
a major role in selective regulation, developmental differences
can lead to variable activation requirements at specific genes
in different cell types. As one example, the Il6 promoter is assem-
bled into inaccessible nucleosomes inmousemacrophages, and
its activation by LPS requires nucleosome remodeling by SWI/
SNF complexes, as well as new protein synthesis for the induc-
tion of nucleosome remodeling (Ramirez-Carrozzi et al., 2009). In
contrast, the same promoter is assembled into open chromatin
in fibroblasts, allowing Il6 activation by LPS in a SWI/SNF-inde-
pendent and protein synthesis-independent manner. These
chromatin differences in two different mature cell types, which
can have a profound influence on the signal transduction and840 Cell 140, 833–844, March 19, 2010 ª2010 Elsevier Inc.transcription factor requirements for Il6 activation, must be
established during macrophage and fibroblast development.
Physiological Relevance of the Mechanistic Variability
The many examples discussed above of mechanistic variability
in the transcriptional response to an inflammatory stimulus
provide considerable potential for the selective regulation of
inducible genes. However, the precise relationship between
this mechanistic diversity and physiological responses remains
poorly understood. As mentioned above, physiological re-
sponses have not been identified that are characterized by
activation of the select subset of genes that require RelA
phosphorylation-dependent recruitment of p300/CBP. Similarly,
physiological settings have not been identified that are charac-
terized by activation of the select subset of genes possessing
methyl H3K9 or methyl H3K27 marks.
Clear connections between mechanistic diversity and selec-
tive regulation have been equally difficult to uncover when
gene regulation in specific physiological settings is first consid-
ered. For example, tolerance to repetitive stimulation of macro-
phages by LPS is a well-characterized process that is thought
to have evolved to protect a host from tissue damage during pro-
longed exposure to a bacterial pathogen. Strong suppression of
transcription occurs primarily at proinflammatory genes, whose
products can lead to tissue damage, while robust activation of
antimicrobial genes ismaintained (Foster et al., 2007). The selec-
tive suppression of some proinflammatory genes involves
changes in chromatin structure and histone modifications
(Foster et al., 2007). However, susceptibility or resistance to
LPS tolerance cannot be connected to a specific NF-kB activa-
tion mechanism or to genes containing a specific chromatin
signature in unstimulated cells. As another example, the key
anti-inflammatory cytokine IL-10 inhibits a select subset of
LPS-induced genes, but without a clear connection to any of
the selective regulatory mechanisms discussed above (Lang
et al., 2002).Most likely, LPS tolerance and the anti-inflammatory
effects of IL-10 involve additional layers of regulation that are not
dependent on a specific NF-kB activation mechanism or chro-
matin signature.
Although much remains to be learned about the connections
between mechanistic diversity and physiological regulation,
a few glimpses of the underlying logic have begun to emerge.
For example, SWI/SNF-independent genes containing CpG
island promoters are generally induced by a diverse range of
stimuli, includingmultiple TLR ligands, TNFa, and serum, consis-
tent with the absence of a nucleosome barrier at the promoter to
limit activation (Ramirez-Carrozzi et al., 2009; Hargreaves et al.,
2009). Conversely, SWI/SNF-dependent genes containing low
CpG promoters are induced more selectively and with greater
tissue specificity, as described above for IRF3-dependent genes
(Ramirez-Carrozzi et al., 2009; Hargreaves et al., 2009).
Differential displacement of the NCoR and SMRT corepres-
sors provides another connection betweenmechanistic diversity
and a specific physiological response. Release of the SMRT
corepressor from its target genes was found to be catalyzed
by the MEKK1 signaling pathway, whereas NCoR binding was
unaffected by this pathway (Ghisletti et al., 2009). Since IFN-g
activates the MEKK1 pathway, this cytokine can lead to the
selective enhancement of SMRT-associated genes, including
Il12b and Ccl2, without enhancing NCoR-associated genes
(Ghisletti et al., 2009). Thus, the differential response to IFN-g
may be dictated, at least in part, by the differential recruitment
of NCoR and SMRT to the promoters of inducible genes during
the development of responsive cell types.
Concluding Remarks
I have highlighted recent progress toward understanding the
molecular mechanisms that underlie the selective activation of
genes by an inflammatory stimulus. Clearly, much has been
learned since studies of inflammatory gene regulation were initi-
ated more than 25 years ago. In particular, the initial view that
the selective activation of an inducible gene is dictated primarily
by the combinatorial binding of a specific set of transcription
factors has been replaced by models with several additional
regulatory layers. From a drug discovery perspective, these
additional layers of regulation suggest attractive new targets
for the therapeutic modulation of distinct subsets of inducible
genes. For example, inhibitors of specific H3K9 demethylases
or H3K27 demethylases may selectively suppress inflammatory
genes that possess H3K9 or H3K27 methylation as a barrier to
activation. Similarly, inhibitors of specific kinases or methylases
responsible for RelA S276 phosphorylation or K37 methylation
may reduce expression of the specific subset of NF-kB target
genes that require phosphorylation or methylation for their
activation.It is important to emphasize that this article focuses on only
two regulatory layers that have been suggested by recent
studies to be major contributors to selectivity: the use of diverse
activation strategies for individual transcription factors like
NF-kB and the need to overcome diverse chromatin barriers
for the activation of different subsets of inducible genes.
However, many other contributors to selective regulation are
known to exist. For example, the numerous homodimeric and
heterodimeric species that can be assembled from the five
NF-kB family members have the potential to regulate distinct
subsets of genes through a variety of mechanisms, including
differential protein-DNA interactions and differential interactions
with co-regulatory molecules (Sen and Smale, 2009). Further-
more, elegant studies have revealed that NF-kB induction is
subject to strict kinetic control that varies from stimulus to stim-
ulus, raising the possibility that the duration of NF-kB induction
mayplay an important role in defining the precise subset of genes
activated in response to a stimulus (Hoffmann and Baltimore,
2006). Selective regulation canalsobedictatedby the sequences
of NF-kB recognition motifs in the promoters of inducible genes,
which may influence the conformation of the DNA-bound NF-kB
dimer and modulate its interaction with coregulatory proteins
(Lefstin and Yamamoto, 1998; Leung et al., 2004).
In addition to the diverse mechanisms that facilitate selective
gene activation by NF-kB and other transcription factors,
numerous strategies have evolved for the attenuation of inflam-
matory gene transcription. Attenuation of an inflammatory
response can be achieved, for example, by the binding of tran-
scriptional repressors to specific target genes, by the active
displacement of NF-kB and other transcription factors from their
target genes, and by the differential and tightly regulated export
of NF-kB complexes from the nucleus (e.g., Gilchrist et al., 2006;
Natoli and Chiocca, 2008; Sen and Smale, 2009). A better under-
standing of these negative regulatory strategies may reveal
additional targets for therapeutic intervention.
It is appropriate to conclude by considering the likely impact of
these diverse contributors to selective gene transcription on the
long-term goal of defining complete gene regulation networks in
response to an inflammatory stimulus. More specifically, a major
goal is to connect each transcription factor that is directly acti-
vated by a stimulus first to its primary response target genes
and then to secondary target genes activated by an increasingly
complex mixture of transcription factors that become expressed
and activated as the response continues. Considerable progress
has been reported toward the elucidation of inflammatory gene
regulation networks through detailed transcriptome analyses,
often coupled to bioinformatic analyses of transcription factor
recognition motifs in the promoters of inducible genes and
genome-wide ChIP analyses of transcription factor binding sites
(Amit et al., 2009; Litvak et al., 2009, and references therein).
These studies have already provided meaningful new insights.
However, the difficulty of using computational and genomics
approaches to rigorously define gene regulation networks is
greatly increased by evidence that target gene activation is
dictated, not only by a specific set of transcription factors, but
also by the need to remove diverse chromatin barriers and the
need for signal-dependent activation and association of diverse
coregulatory molecules. Because of this diversity, it will likely beCell 140, 833–844, March 19, 2010 ª2010 Elsevier Inc. 841
necessary to incorporate chromatin properties of target genes
into computational strategies for defining gene regulation
networks. It may also be necessary to consider coregulatory
requirements for transcription factor function at each target
gene, as well as the signal transduction pathways needed to
activate each coregulatory function. The successful integration
of emerging mechanistic insights with bioinformatic and geno-
mics strategies should move the field closer to the goal of eluci-
dating definitive inflammatory gene regulation networks.
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